$3.190
-0.179 (-5.62%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
GALT Prediction & Forecast by Similar Chart Analysis
Alphio's GALT stock price prediction model matches the current Galectin Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.21 (+0.72%). The 1-week path is $3.29 (+3.27%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Galectin Therapeutics Inc Stock?
Galectin Therapeutics Inc is not a good buy right now due to its significantly negative financial performance and technical indicators. The current price is $3.19, with a 1-year change of -37.45%, indicating a downward trend. Additionally, the RSI is at 17.639, suggesting that the stock is heavily oversold, which may lead to further declines rather than recovery in the near term.
GALT stock price ended at $3.19 on Friday, after losing -5.62%
Galectin Therapeutics Inc (GALT) last closed at $3.19, losing -5.62%. These facts feed the 1-day and 1-week GALT price prediction above.
Analyst Consensus
Galectin Therapeutics Inc (GALT): 3 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Galectin Therapeutics Inc (GALT) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches GALT, ranked by similarity.
Seasonality analysis for GALT
Historically the probability of a positive October return for GALT is 73.02%. November offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for GALT
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $2.59 | $2.79 | $3.00 | -12.51% |
| Nov 2026 | $2.21 | $2.50 | $2.53 | -21.66% |
| Dec 2026 | $2.90 | $3.34 | $3.84 | +4.86% |
In 2026, Galectin Therapeutics Inc (GALT) is projected to range from $2.21 to $3.84.
Galectin Therapeutics Inc 2026 monthly forecast
In Oct 2026, Galectin Therapeutics Inc is projected to average $2.79, with a low of $2.59 and high of $3.00.
In Nov 2026, Galectin Therapeutics Inc is projected to average $2.50, with a low of $2.21 and high of $2.53.
In Dec 2026, Galectin Therapeutics Inc is projected to average $3.34, with a low of $2.90 and high of $3.84.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.